Companies / Ani Pharmaceuticals Inc

Ani Pharmaceuticals Inc

Nasdaq: ANIPCIK 1023024PRINCETON, NJ
Insider flow · last 90 daysNet sells $707.5K

Financials · FY2025

Revenue$883.37M
Net income$78.34M
Total debt$280.15M
Cash$360.21M
Diluted EPS$3.32
Shares outstanding23.0M

Ownership

23.0M shares outstanding · as of Jul 31, 2026
5.3%Insiders
Ownership
Insiders5.29%1,214,340
Institutions97.05%22,281,170
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 15

View all →
Insider% of sharesShares
Lalwani NikhilCEOPRESIDENT & CEO · Director
1.52%349,889
Carey Stephen P.SVP & CFO
0.77%177,543
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS · Director
0.44%101,056
Mutz ChristopherHEAD OF RARE DISEASE
0.40%91,309
Gutwerg OriSVP, GENERICS
0.34%78,696
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
0.34%77,890
Gassert ChadSVP - CORP. DEV. & STRATEGY
0.33%74,916
Davis KristaSVP, CHIEF HR OFFICER
0.23%51,946
Haughey ThomasDirector
0.17%38,878
Walsh Patrick DDirector
0.17%38,432

Institutional holders 291

View all →
HolderValue% of shares
BlackRock, Inc.$244.92M12.89%
Vanguard Group Inc$103.02M5.68%
State Street Corporation$68.86M3.62%
Tang Capital Management, LLC$54.41M3.08%
GoldenTree Asset Management LP$51.30M2.91%
Global Alpha Capital Management Ltd.$46.59M2.57%
Millennium Management LLC$45.53M2.58%
Arrowstreet Capital, Limited Partnership$43.40M2.46%
Dimensional Fund Advisors LP$38.50M2.12%
Soleus Capital Management, L.P.$38.38M2.12%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 26, 2026Lalwani Nikhil
CEO
GrantCommon Stock$5.83M+76K
+21.08%
434,166
1.89% of shares
low
May 11, 2026Lalwani Nikhil
CEO
SellCommon Stock$4.27M-55K
-13.58%
349,889
1.52% of shares
medium
Feb 11, 2026Lalwani Nikhil
CEO
OtherCommon Stock$2.34M-31K
-7.46%
380,560
1.66% of shares
low
Feb 26, 2026Carey Stephen P.
Executive
GrantCommon Stock$1.72M+22K
+13.07%
192,316
0.84% of shares
low
Feb 26, 2026Mutz Christopher
Executive
GrantCommon Stock$1.64M+21K
+25.11%
106,146
0.46% of shares
low
Mar 7, 2026Lalwani Nikhil
CEO
OtherCommon Stock$1.26M-17K
-4.04%
404,889
1.76% of shares
low
Feb 26, 2026Cook Meredith
Executive
GrantCommon Stock$1.07M+14K
+20.57%
81,445
0.35% of shares
low
Feb 26, 2026Gutwerg Ori
Executive
GrantCommon Stock$1.00M+13K
+17.04%
89,063
0.39% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ANIP——00182C103—